Healthcare AI Funding Accelerates Amid Broader Venture Selectivity

Forus reportedly raised $150M at a $3B valuation after a $160M May financing, making healthcare workflow and drug-access AI a notable late-stage funding signal. At the same time, European wealthtech funding reportedly fell 46% quarter over quarter and 73% year over year in Q2 2026, highlighting investor preference for revenue-backed infrastructure and sharper selectivity.